Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
Lumos Pharma | 8-K: Current report
Lumos Pharma | DEFA14A: Others
Lumos Pharma | DEF 14A: Definitive information statements
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Current report
Lumos Pharma | 8-K: Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates
Lumos Pharma | DEFA14A: Others
No Data